Natural Product (NP) Details
General Information of the NP (ID: NP0395) | |||||
---|---|---|---|---|---|
Name |
Nobiletin
|
||||
Synonyms |
Hexamethoxyflavone; 3',4',5,6,7,8-Hexamethoxyflavone; 5,6,7,8,3',4'-Hexamethoxyflavone; UNII-D65ILJ7WLY; 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one; NSC-76751; D65ILJ7WLY; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-chromen-4-one; CHEMBL76447; Nobiletin (Hexamethoxyflavone); CHEBI:7602; NSC76751; MFCD03273560; Flavone, 5,6,7,8,3',4'-hexamethoxy; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-; SMR000156231; CCRIS 9012; NSC 76751; CPD000156231; Nobiletin, >=97%; Spectrum2_001697; Spectrum3_000921; Spectrum4_001020; KBioGR_001519; MLS000574877; MLS000759462; MLS000877030; MLS001424129; Nobiletin, analytical standard; SCHEMBL244029; SPECTRUM1505268; SPBio_001654; MEGxp0_000930; ACon1_000921; KBio3_001922; DTXSID30197275; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromen-4-one; HMS2051D09; HMS2234A09; HMS3373C14; HMS3393D09; HMS3651G20; HY-N0155; ZINC1531669; 3'4'5,6,7,8-Hexamethoxyflavone; 3,4,5,6,7,8-Hexamethoxyflavone; ANW-42631; BDBM50338976; CCG-38781; CN0043; LMPK12111468; NSC618903; STL565829; AKOS015965334; NOBILETIN, 20% (Technical Grade); AC-1023; CS-5518; MCULE-1015144950; NC00186; NSC-618903; SDCCGMLS-0066776.P001; NCGC00095703-01; NCGC00095703-02; NCGC00169228-01; 5,6,7,8,3'',4''-hexamethoxyflavone; AK168175; AS-17452; NCI60_041691; DB-050181; FT-0686667; N0871; N1311; S2333; SW197566-2; V0181; C10112; SR-01000712262; Q-100511; Q2402963; SR-01000712262-5; BRD-K06753942-001-02-0; 2-(3,4-Dimethoxy-phenyl)-5,6,7,8-tetramethoxy-chromen-4-one; 4H-1-Benzopyran-4-one,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-; 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one, 9CI; 3 inverted exclamation mark ,4 inverted exclamation mark ,5,6,7,8-HEXAMETHOXYFLAVONE; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy- (9CI)
Click to Show/Hide
|
||||
Species Origin | Ageratum conyzoides ... | Click to Show/Hide | |||
Ageratum conyzoides | |||||
Disease | Breast cancer [ICD-11: 2C60] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C21H22O8
|
||||
PubChem CID | |||||
Canonical SMILES |
COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC
|
||||
InChI |
1S/C21H22O8/c1-23-13-8-7-11(9-15(13)24-2)14-10-12(22)16-17(25-3)19(26-4)21(28-6)20(27-5)18(16)29-14/h7-10H,1-6H3
|
||||
InChIKey |
MRIAQLRQZPPODS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 478-01-3
|
||||
Herb ID | |||||
ETMC ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Sorafenib | Renal cell carcinoma | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | CDKN1A | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | RB1 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | ||
Experimental
Result(s) |
NOB and SOR combination was more effective than SOR and NOB alone and reduced the exposure time for SOR and NOB in PC-3 cells. NOB and SOR combination significantly caused much more apoptotic cell death and cell cycle arrest at G0/G1 phase by up-regulation of Bax, Rb1, and CDKN1A levels in PC-3 cells. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Apoptosis mediating surface antigen FAS (FAS) | Molecule Info | [3] | |
Apoptosis regulator BAX (BAX) | Molecule Info | [4] | ||
Protein kinase B alpha (AKT1) | Molecule Info | [5] | ||
KEGG Pathway | MAPK signaling pathway | Click to Show/Hide | ||
2 | ErbB signaling pathway | |||
3 | Ras signaling pathway | |||
4 | Rap1 signaling pathway | |||
5 | cGMP-PKG signaling pathway | |||
6 | cAMP signaling pathway | |||
7 | Chemokine signaling pathway | |||
8 | HIF-1 signaling pathway | |||
9 | FoxO signaling pathway | |||
10 | Sphingolipid signaling pathway | |||
11 | mTOR signaling pathway | |||
12 | PI3K-Akt signaling pathway | |||
13 | AMPK signaling pathway | |||
14 | Apoptosis | |||
15 | Adrenergic signaling in cardiomyocytes | |||
16 | VEGF signaling pathway | |||
17 | Osteoclast differentiation | |||
18 | Focal adhesion | |||
19 | Tight junction | |||
20 | Signaling pathways regulating pluripotency of stem cells | |||
21 | Platelet activation | |||
22 | Toll-like receptor signaling pathway | |||
23 | Jak-STAT signaling pathway | |||
24 | T cell receptor signaling pathway | |||
25 | B cell receptor signaling pathway | |||
26 | Fc epsilon RI signaling pathway | |||
27 | Fc gamma R-mediated phagocytosis | |||
28 | TNF signaling pathway | |||
29 | Neurotrophin signaling pathway | |||
30 | Cholinergic synapse | |||
31 | Dopaminergic synapse | |||
32 | Insulin signaling pathway | |||
33 | Progesterone-mediated oocyte maturation | |||
34 | Estrogen signaling pathway | |||
35 | Prolactin signaling pathway | |||
36 | Thyroid hormone signaling pathway | |||
37 | Adipocytokine signaling pathway | |||
38 | Glucagon signaling pathway | |||
39 | Regulation of lipolysis in adipocytes | |||
40 | Non-alcoholic fatty liver disease (NAFLD) | |||
41 | Carbohydrate digestion and absorption | |||
42 | Chagas disease (American trypanosomiasis) | |||
43 | Toxoplasmosis | |||
44 | Tuberculosis | |||
45 | Hepatitis C | |||
46 | Hepatitis B | |||
47 | Measles | |||
48 | Influenza A | |||
49 | HTLV-I infection | |||
50 | Epstein-Barr virus infection | |||
51 | Pathways in cancer | |||
52 | Proteoglycans in cancer | |||
53 | Colorectal cancer | |||
54 | Renal cell carcinoma | |||
55 | Pancreatic cancer | |||
56 | Endometrial cancer | |||
57 | Glioma | |||
58 | Prostate cancer | |||
59 | Melanoma | |||
60 | Chronic myeloid leukemia | |||
61 | Acute myeloid leukemia | |||
62 | Small cell lung cancer | |||
63 | Non-small cell lung cancer | |||
64 | Central carbon metabolism in cancer | |||
65 | Choline metabolism in cancer | |||
66 | Cytokine-cytokine receptor interaction | |||
67 | p53 signaling pathway | |||
68 | Natural killer cell mediated cytotoxicity | |||
69 | Type I diabetes mellitus | |||
70 | Alzheimer's disease | |||
71 | African trypanosomiasis | |||
72 | Herpes simplex infection | |||
73 | Autoimmune thyroid disease | |||
74 | Allograft rejection | |||
75 | Graft-versus-host disease | |||
NetPath Pathway | TSH Signaling Pathway | Click to Show/Hide | ||
2 | IL2 Signaling Pathway | |||
3 | TCR Signaling Pathway | |||
Panther Pathway | Angiogenesis | Click to Show/Hide | ||
2 | Apoptosis signaling pathway | |||
3 | EGF receptor signaling pathway | |||
4 | Endothelin signaling pathway | |||
5 | FGF signaling pathway | |||
6 | Huntington disease | |||
7 | Hypoxia response via HIF activation | |||
8 | Inflammation mediated by chemokine and cytokine signaling pathway | |||
9 | Insulin/IGF pathway-protein kinase B signaling cascade | |||
10 | Interleukin signaling pathway | |||
11 | PI3 kinase pathway | |||
12 | T cell activation | |||
13 | VEGF signaling pathway | |||
14 | p53 pathway | |||
15 | Ras Pathway | |||
16 | p53 pathway by glucose deprivation | |||
17 | p53 pathway feedback loops 2 | |||
18 | CCKR signaling map ST | |||
19 | FAS signaling pathway | |||
Pathwhiz Pathway | Intracellular Signalling Through Adenosine Receptor A2a and Adenosine | Click to Show/Hide | ||
2 | Intracellular Signalling Through Adenosine Receptor A2b and Adenosine | |||
3 | Fc Epsilon Receptor I Signaling in Mast Cells | |||
4 | Insulin Signalling | |||
5 | Leucine Stimulation on Insulin Signaling | |||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | Click to Show/Hide | ||
2 | Fc-epsilon receptor I signaling in mast cells | |||
3 | Endothelins | |||
4 | BCR signaling pathway | |||
5 | LPA receptor mediated events | |||
6 | Insulin Pathway | |||
7 | IL4-mediated signaling events | |||
8 | TCR signaling in naï | |||
9 | ||||
10 | Plasma membrane estrogen receptor signaling | |||
11 | CD40/CD40L signaling | |||
12 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||
13 | Signaling events mediated by PTP1B | |||
14 | S1P3 pathway | |||
15 | Coregulation of Androgen receptor activity | |||
16 | Reelin signaling pathway | |||
17 | Integrin-linked kinase signaling | |||
18 | TCR signaling in naï | |||
19 | ||||
20 | Angiopoietin receptor Tie2-mediated signaling | |||
21 | FAS (CD95) signaling pathway | |||
22 | Thromboxane A2 receptor signaling | |||
23 | Regulation of Telomerase | |||
24 | FOXA2 and FOXA3 transcription factor networks | |||
25 | Glucocorticoid receptor regulatory network | |||
26 | mTOR signaling pathway | |||
27 | CXCR4-mediated signaling events | |||
28 | IGF1 pathway | |||
29 | FoxO family signaling | |||
30 | IL2 signaling events mediated by PI3K | |||
31 | Ceramide signaling pathway | |||
32 | p75(NTR)-mediated signaling | |||
33 | E-cadherin signaling in the nascent adherens junction | |||
34 | amb2 Integrin signaling | |||
35 | Integrins in angiogenesis | |||
36 | IFN-gamma pathway | |||
37 | ErbB1 downstream signaling | |||
38 | ErbB2/ErbB3 signaling events | |||
39 | IL6-mediated signaling events | |||
40 | E-cadherin signaling in keratinocytes | |||
41 | Nephrin/Neph1 signaling in the kidney podocyte | |||
42 | Retinoic acid receptors-mediated signaling | |||
43 | IL8- and CXCR2-mediated signaling events | |||
44 | Signaling events mediated by the Hedgehog family | |||
45 | Nongenotropic Androgen signaling | |||
46 | Hedgehog signaling events mediated by Gli proteins | |||
47 | Caspase Cascade in Apoptosis | |||
48 | CXCR3-mediated signaling events | |||
49 | VEGFR1 specific signals | |||
50 | Signaling events mediated by Stem cell factor receptor (c-Kit) | |||
51 | Signaling events mediated by VEGFR1 and VEGFR2 | |||
52 | a6b1 and a6b4 Integrin signaling | |||
53 | Aurora A signaling | |||
54 | Insulin-mediated glucose transport | |||
55 | Class I PI3K signaling events mediated by Akt | |||
56 | IL8- and CXCR1-mediated signaling events | |||
57 | HIF-1-alpha transcription factor network | |||
58 | p53 pathway | |||
59 | Trk receptor signaling mediated by PI3K and PLC-gamma | |||
60 | VEGFR3 signaling in lymphatic endothelium | |||
61 | FGF signaling pathway | |||
62 | p73 transcription factor network | |||
63 | Direct p53 effectors | |||
64 | HIV-1 Nef: Negative effector of Fas and TNF-alpha | |||
65 | Validated transcriptional targets of TAp63 isoforms | |||
Reactome | Activation of BAD and translocation to mitochondria | Click to Show/Hide | ||
2 | GPVI-mediated activation cascade | |||
3 | PIP3 activates AKT signaling | |||
4 | Translocation of GLUT4 to the plasma membrane | |||
5 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |||
6 | AKT phosphorylates targets in the cytosol | |||
7 | AKT phosphorylates targets in the nucleus | |||
8 | Negative regulation of the PI3K/AKT network | |||
9 | eNOS activation | |||
10 | AKT-mediated inactivation of FOXO1A | |||
11 | Integrin alphaIIb beta3 signaling | |||
12 | Deactivation of the beta-catenin transactivating complex | |||
13 | CD28 dependent PI3K/Akt signaling | |||
14 | CTLA4 inhibitory signaling | |||
15 | G beta:gamma signalling through PI3Kgamma | |||
16 | KSRP (KHSRP) binds and destabilizes mRNA | |||
17 | VEGFR2 mediated vascular permeability | |||
18 | TP53 Regulates Metabolic Genes | |||
19 | Constitutive Signaling by AKT1 E17K in Cancer | |||
20 | FasL/ CD95L signaling | |||
WikiPathways | Toll-like receptor signaling pathway | Click to Show/Hide | ||
2 | DNA Damage Response (only ATM dependent) | |||
3 | TCR Signaling Pathway | |||
4 | Notch Signaling Pathway | |||
5 | EPO Receptor Signaling | |||
6 | IL-2 Signaling Pathway | |||
7 | Insulin Signaling | |||
8 | Endochondral Ossification | |||
9 | EGF/EGFR Signaling Pathway | |||
10 | IL-4 Signaling Pathway | |||
11 | TGF beta Signaling Pathway | |||
12 | IL-6 signaling pathway | |||
13 | Wnt Signaling Pathway Netpath | |||
14 | Copper homeostasis | |||
15 | Extracellular vesicle-mediated signaling in recipient cells | |||
16 | Apoptosis-related network due to altered Notch3 in ovarian cancer | |||
17 | IL-3 Signaling Pathway | |||
18 | Cardiac Hypertrophic Response | |||
19 | Translocation of GLUT4 to the Plasma Membrane | |||
20 | Regulation of mRNA Stability by Proteins that Bind AU-rich Elements | |||
21 | PIP3 activates AKT signaling | |||
22 | Signal Transduction of S1P Receptor | |||
23 | T-Cell Receptor and Co-stimulatory Signaling | |||
24 | Primary Focal Segmental Glomerulosclerosis FSGS | |||
25 | Apoptosis | |||
26 | Alpha 6 Beta 4 signaling pathway | |||
27 | BDNF signaling pathway | |||
28 | Integrated Pancreatic Cancer Pathway | |||
29 | Oncostatin M Signaling Pathway | |||
30 | Corticotropin-releasing hormone | |||
31 | Interleukin-11 Signaling Pathway | |||
32 | AGE/RAGE pathway | |||
33 | TNF alpha Signaling Pathway | |||
34 | B Cell Receptor Signaling Pathway | |||
35 | Prostate Cancer | |||
36 | Signaling Pathways in Glioblastoma | |||
37 | TSLP Signaling Pathway | |||
38 | IL17 signaling pathway | |||
39 | IL-7 Signaling Pathway | |||
40 | Regulation of Microtubule Cytoskeleton | |||
41 | TWEAK Signaling Pathway | |||
42 | FSH signaling pathway | |||
43 | Leptin signaling pathway | |||
44 | TSH signaling pathway | |||
45 | RANKL/RANK Signaling Pathway | |||
46 | Integrated Breast Cancer Pathway | |||
47 | SREBP signalling | |||
48 | Integrated Cancer pathway | |||
49 | IL-1 signaling pathway | |||
50 | Metabolism of nitric oxide | |||
51 | Integrin-mediated Cell Adhesion | |||
52 | TFs Regulate miRNAs related to cardiac hypertrophy | |||
53 | MicroRNAs in cardiomyocyte hypertrophy | |||
54 | Angiogenesis | |||
55 | TOR Signaling | |||
56 | Regulation of toll-like receptor signaling pathway | |||
57 | AMPK Signaling | |||
58 | Androgen receptor signaling pathway | |||
59 | IL-5 Signaling Pathway | |||
60 | DNA Damage Response | |||
61 | Apoptosis Modulation by HSP70 | |||
62 | MAPK Signaling Pathway | |||
63 | FAS pathway and Stress induction of HSP regulation | |||
64 | Adipogenesis | |||
65 | Allograft Rejection | |||
66 | Alzheimers Disease | |||
67 | Extrinsic Pathway for Apoptosis | |||
68 | Apoptosis Modulation and Signaling | |||
69 | miRNA Regulation of DNA Damage Response |